phorbol 12,13-dibutyrate has been researched along with Thromboembolism in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chou, DS; Hsiao, G; Lin, CH; Lin, KH; Shen, MY; Sheu, JR; Wang, Y | 1 |
Chen, TG; Chou, DS; Lee, JJ; Lin, KH; Shen, CH; Sheu, JR | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and Thromboembolism
Article | Year |
---|---|
Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Topics: Animals; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Humans; In Vitro Techniques; Metallothionein; Mice; Models, Biological; Phorbol 12,13-Dibutyrate; Phosphatidylinositols; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Signal Transduction; Thromboembolism; Thromboxane B2 | 2003 |
Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
Topics: Blood Platelets; Caffeic Acids; Cell Adhesion Molecules; Cyclic AMP; Cyclic GMP; Humans; Microfilament Proteins; Phenylethyl Alcohol; Phorbol 12,13-Dibutyrate; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Thromboembolism | 2007 |